NCT06371521

Brief Summary

Sportlegs is a commercially available dietary/sports supplement. It is manufactured by a local, Colorado-based company: Sport Specifics Inc. Although Sportlegs has been on the market for approximately 20-years, very little empirical research has been completed to determine if Sportlegs improves exercise performance. Sport Specifics Inc. has commissioned Colorado State University to investigate the ergogenic effects of Sportlegs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jan 2024

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 24, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

4 months

First QC Date

April 14, 2024

Last Update Submit

July 11, 2024

Conditions

Keywords

Exercise PerformanceErgogenic AidLactate SupplementMaximal Oxygen UptakeFunctional Threshold Power

Outcome Measures

Primary Outcomes (4)

  • Maximal Oxygen Uptake

    To compare VO2max, determined during incremental stationary cycle ergometer exercise, in young healthy adults after acute ingestion of placebo and Sportlegs.

    30 minutes following Sportlegs or Placebo ingestion.

  • Lactate Threshold

    To compare lactate threshold, determined during incremental stationary cycle ergometer exercise, in young healthy adults after acute ingestion of placebo and Sportlegs.

    30 minutes following Sportlegs or Placebo ingestion

  • Rating of Perceived Exertion (RPE)

    To compare perceived rates of exertion, determined during stationary cycle ergometer exercise, in young healthy adults after acute ingestion of placebo and Sportlegs.

    During the VO2max and maximal mean power tests

  • Maximal sustained mean power

    To compare the maximal mean power that can be sustained on a cycle ergometer for 20-min, in young healthy adults after acute ingestion of placebo and Sportlegs.

    30 minutes following Sportlegs or Placebo ingestion

Study Arms (2)

VO2max and Lactate Threshold

EXPERIMENTAL

Participants will ingest either Sportlegs or placebo. The Sportlegs (and placebo) will be ingested as dietary capsules taken with water. 30-minutes after ingestion, the VO2max and lactate threshold testing will commence. This will involve a graded exercise test on a cycle ergometer to volitional fatigue. Heart rate and gas exchange will be measured prior to and throughout the exercise test. Blood will be sampled approximately every 60-seconds from a venous catheter placed in a hand or wrist vein, or from a finger using a lancet and cappillary tube. The amount of blood to be sampled is up to \~2-3 ml per sample, totalling less than 40 mL per lab visit. The blood will be immediately analyzed for lactate concentration using an automated analyzer. Ratings of Perceived Exertion will be recorded every \~2 minutes. VO2max and lactate threshold are considered important predictors of exercise performance.

Dietary Supplement: SportlegsDietary Supplement: Placebo

Maximal Mean Power Output

EXPERIMENTAL

The Sportlegs (and placebo) will be ingested as dietary capsules taken with water. 30-minutes after ingestion, participants will begin the FTP20 test. Following a brief, standardized warm-up, participants will exercise on a stationary cycle ergometer at the highest intensity they are able to sustain for 20-minutes. This is akin to a "time-trial" where cyclists cover as greater distance as possible during a pre-determined period of time. During the FTP20 test, work rate will be monitored and recorded, as will heart rate (monitored continuously but only recorded every 5-minutes via short range telemetry or ECG). Rating of perceived exertion will also be assessed and recorded every 5-minutes. The FTP20 test is considered an important predictor of exercise performance.

Dietary Supplement: SportlegsDietary Supplement: Placebo

Interventions

SportlegsDIETARY_SUPPLEMENT

Sportlegs contains lactate (from calcium lactate pentahydrate and magnesium lactate dihydrate), magnesium (from magnesium lactate dihydrate), calcium (from calcium lactate pentahydrate), and vitamin D (as cholecalciferol).

Maximal Mean Power OutputVO2max and Lactate Threshold
PlaceboDIETARY_SUPPLEMENT

Empty Capsules to serve as a placebo control

Maximal Mean Power OutputVO2max and Lactate Threshold

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-30 years (inclusive)
  • Minimum of 150 minutes/week of moderate intensity endurance exercise during the previous 12-months.

You may not qualify if:

  • Pregnancy
  • Breastfeeding
  • Use of Sportlegs within the previous 4-weeks
  • Use of magnesium supplements within the previous 4-weeks
  • Unwillingness to abstain from the use of other potentially ergogenic dietary supplements throughout the duration of participation in the study
  • Inability or unwillingness to perform vigorous cycle ergometer exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Colorado State University

Fort Collins, Colorado, 80523, United States

Location

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigators and Participants are both blinded to whether the participants will be consuming Sportlegs or Placebo during a given study visit.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized, Placebo-Controlled, Double Blind Crossover Intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 14, 2024

First Posted

April 17, 2024

Study Start

January 24, 2024

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

July 12, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations